Morning Overview on MSN
A nasal spray reversed signs of brain aging in early tests, and a patent is already filed
Researchers at Texas A&M University reported that two intranasal doses of extracellular vesicles derived from human neural ...
Researchers discovered that a potential drug developed at Michigan Medicine treats severe fatty liver disease by improving gut health, according to a study published in The Journal of Clinical ...
Globally recognized leader in early-phase oncology clinical development and experimental therapeuticsStrengthens strategic ...
MedPage Today on MSN
Alzheimer's Biomarkers Change After Tuberculosis Vaccination
BCG vaccine altered immune responses and modified amyloid-beta, study shows ...
The gut microbiome is no longer viewed as a mere spectator in cancer development – it is increasingly recognized as a key ...
Cancer remains notoriously difficult to treat, partly because tumors co‑opt their surrounding environment, including the ...
Breakthrough T1D, the leading global type 1 diabetes (T1D) research and advocacy organization and SAB Biotherapeutics, Inc. (Nasdaq: SABS), a clinical-stage biopharmaceutical company developing a ...
Insilico Medicine ("Insilico," HKEX: 3696), a clinical-stage biotechnology company powered by generative AI, today announced the initiation of the Phase III clinical trial for Rentosertib, its ...
Researchers discovered that a potential drug developed at Michigan Medicine treats severe fatty liver disease by improving ...
Curious about how to make music with raw oscillators and other pieces of exotic Cold War-era test equipment? Don your lab ...
Breakthrough T1D, the leading global type 1 diabetes (T1D) research and advocacy organization and SAB Biotherapeutics, Inc. (Nasdaq: SABS), a clinical-stage biopharmaceutical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results